There is always a well-known solution to every human problem — neat, plausible, and wrong. – H. L. Mencken
The report's authors conclude that there are eight factors that are the basis for the access to medicines problem, and that these must be addressed on a global basis by a concerted collaboration by stakeholders as diverse as the biopharmaceutical industry, governments, multilateral organizations, care
Download Full Comments Below
Access To Medicines Consolidated Final -9-24-16-v2
Dear Colleagues,This month marks my one-year anniversary as BIO’s CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever witnessed such awe-inspiring science. Today, we…
Re: BIO Comments on Office of Management and Budget (OMB) Statistical Policy Directive No. 8 North American Industry Classification System (NAICS)-Request forComments on Possible Revisions for 2027 (USBC–2024–0032)Dear Ms. Orvis,The Biotechnology…
Under the 340B program, participating manufacturers must offer 340B pricing on their covered outpatient drugs by covered entities, as a condition of having those drugs federally payable under Medicare Part B and Medicaid. Critically, Congress…
There is always a well-known solution to every human problem — neat, plausible, and wrong. – H. L. Mencken
The report's authors conclude that there are eight factors that are the basis for the access to medicines problem, and that these must be addressed on a global basis by a concerted collaboration by stakeholders as diverse as the biopharmaceutical industry, governments, multilateral organizations, care